BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8151678)

  • 1. A particle counting immunoassay for the direct detection of Clostridium difficile serogroup specific antigen in faecal specimens.
    Avesani A; Cambiaso C; Guarin JL; Lick A; Delmée M
    J Med Microbiol; 1994 Apr; 40(4):270-4. PubMed ID: 8151678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of six commercial assays for the rapid detection of Clostridium difficile toxin and/or antigen in stool specimens.
    Vanpoucke H; De Baere T; Claeys G; Vaneechoutte M; Verschraegen G
    Clin Microbiol Infect; 2001 Feb; 7(2):55-64. PubMed ID: 11298143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of biosite triage Clostridium difficile panel for rapid detection of Clostridium difficile in stool samples.
    Landry ML; Topal J; Ferguson D; Giudetti D; Tang Y
    J Clin Microbiol; 2001 May; 39(5):1855-8. PubMed ID: 11326003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of four methods for detection of Clostridium difficile or C. difficile toxin: cytotoxin assay, culture, latex agglutination, and a new rapid immunoassay (C. difficile toxin A test).
    Fille M; Larcher C; Dierich MP; Allerberger F
    Z Gastroenterol; 1998 Feb; 36(2):143-9. PubMed ID: 9544497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a commercial latex agglutination assay for screening for Clostridium difficile-associated disease.
    Stella PA
    Clin Lab Sci; 1994; 7(5):311-3. PubMed ID: 10150387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of a rapid latex test for the detection of Clostridium difficile in fecal specimens.
    Ryan RW; Kwasnik I; Clout D; Tilton RC
    Ann Clin Lab Sci; 1987; 17(4):232-5. PubMed ID: 3619398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter evaluation of four methods for Clostridium difficile detection: ImmunoCard C. difficile, cytotoxin assay, culture, and latex agglutination.
    Staneck JL; Weckbach LS; Allen SD; Siders JA; Gilligan PH; Coppitt G; Kraft JA; Willis DH
    J Clin Microbiol; 1996 Nov; 34(11):2718-21. PubMed ID: 8897171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of two-stage algorithm in the diagnosis of patients with low levels of Clostridium difficile toxins A/B in feces confirmed by using enzyme immunoassay].
    Nurzyńska G; Pituch H; Kamola R; Kopeć ES
    Med Dosw Mikrobiol; 2013; 65(4):263-8. PubMed ID: 24730214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The problems of rapid diagnosis of Clostridium difficile as causative agent of antibiotic-associated pseudomembranous colitis].
    Lanzendörfer H; Wüst J; Altwegg M
    Schweiz Rundsch Med Prax; 1991 Jan; 80(1-2):15-9. PubMed ID: 1990415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Clostridium difficile enterotoxin gene in clinical specimens by the polymerase chain reaction.
    Boondeekhun HS; Gurtler V; Odd ML; Wilson VA; Mayall BC
    J Med Microbiol; 1993 May; 38(5):384-7. PubMed ID: 8487296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin.
    Ticehurst JR; Aird DZ; Dam LM; Borek AP; Hargrove JT; Carroll KC
    J Clin Microbiol; 2006 Mar; 44(3):1145-9. PubMed ID: 16517916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of culture in the diagnosis of Clostridium difficile infection.
    Bond F; Payne G; Borriello SP; Humphreys H
    Eur J Clin Microbiol Infect Dis; 1995 Mar; 14(3):223-6. PubMed ID: 7614964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A rapid test for detecting Clostridium difficile].
    Karsch W; Strelau E; Fischer E
    Z Gesamte Hyg; 1989 Oct; 35(10):606-7. PubMed ID: 2618112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of three enzyme immunoassays for detection of Clostridium difficile toxins A and B].
    Ould-Hocine ZF; Djibo N; Deforges L; Legrand P; Cattoir V
    Pathol Biol (Paris); 2008; 56(7-8):424-8. PubMed ID: 18824307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation of the presence of Clostridium difficile in antibiotic associated diarrhea patients by culture and toxin detection methods].
    Altindiş M; Usluer S; Ciftçi H; Tunç N; Cetinkaya Z; Aktepe OC
    Mikrobiyol Bul; 2007 Jan; 41(1):29-37. PubMed ID: 17427550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Vidas C. difficile and Quik Chek-60 glutamate dehydrogenase assays for the detection of Clostridium difficile in faecal samples.
    Carson KC; Riley TV
    Pathology; 2016 Aug; 48(5):506-8. PubMed ID: 27311869
    [No Abstract]   [Full Text] [Related]  

  • 17. Performance of the TechLab C. DIFF CHEK-60 enzyme immunoassay (EIA) in combination with the C. difficile Tox A/B II EIA kit, the Triage C. difficile panel immunoassay, and a cytotoxin assay for diagnosis of Clostridium difficile-associated diarrhea.
    Snell H; Ramos M; Longo S; John M; Hussain Z
    J Clin Microbiol; 2004 Oct; 42(10):4863-5. PubMed ID: 15472364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing ImmunoCard with two EIA assays for Clostridium difficile toxins.
    Chan EL; Seales D; Drum H
    Clin Lab Sci; 2009; 22(2):81-5. PubMed ID: 19534439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of a commercially available enzyme immunoassay for the detection of Clostridium difficile toxin A.
    Gilligan PH; Walden TP; Kelly WF; Wait KJ; Kraft JA; Willis DH
    Arch Pathol Lab Med; 1993 May; 117(5):507-10. PubMed ID: 8489340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of TechLab C. DIFF QUIK CHEK and TechLab C. DIFFICILE TOX A/B II for the detection of Clostridium difficile in stool samples.
    Reyes RC; John MA; Ayotte DL; Covacich A; Milburn S; Hussain Z
    Diagn Microbiol Infect Dis; 2007 Sep; 59(1):33-7. PubMed ID: 17662566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.